OTLK
Outlook Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.68
+4.48%Leverage
- Debt / equity
- -1.77x
- Net debt / equity
- -0.69x
- Debt / assets
- 0.70x
- Debt / EBITDA
- -0.30x
- Net debt / EBITDA
- -0.12x
Liquidity & coverage
- Current ratio
- 0.81x
- Quick ratio
- 0.63x
- Cash ratio
- 0.39x
- Interest coverage
- -210.62x
- EBITDA / interest
- -235.78x
- Working capital
- -$5.5M
Cash & dividend
- FCF / debt
- -3.10x
- Cash flow / debt
- -3.10x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026